SRPT - Company ID 0000873303
The table below shows Sarepta Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $801.28M | $1.10B | $428.43M | $966.78M | $2.12B | $1.50B |
| Short-term investments | $138.37M | $251.78M | $1.25B | $1.02B | $435.92M | $435.92M |
| Receivables | $398.23M | $601.99M | $400.33M | $214.63M | $152.99M | $101.34M |
| Inventory | $914.74M | $749.96M | $322.86M | $203.97M | $186.21M | $231.96M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.54B |
| $3.07B |
| $2.58B |
| $2.56B |
| $2.60B |
| $2.49B |
| Property, plant & equipment | $345.13M | $340.34M | $227.15M | $180.04M | $191.16M | $190.43M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $3.35B | $3.96B | $3.26B | $3.13B | $3.15B | $2.98B |
| Accounts payable | $280.84M | $214.44M | $164.92M | $95.88M | $76.74M | $111.09M |
| Total current liabilities | $1.10B | $731.68M | $653.66M | $619.60M | $452.73M | $416.03M |
| Long-term debt | $828.97M | $1.14B | $1.24B | $1.54B | - | - |
| Total liabilities | $2.21B | $2.44B | $2.41B | $2.74B | $2.22B | $2.22B |
| Retained earnings | -$4.88B | -$4.21B | -$4.45B | -$3.91B | -$3.21B | -$2.85B |
| Total equity | $1.14B | $1.53B | $859.34M | $384.95M | $928.01M | $761.76M |